Clinical Trials Browser

Phase 1 × Phase IB × 90 days × Clear all

NCT07318324 2026-01-06

Phase Ib Study of Avutometinib, Defactinib, and Everolimus in RAS Pathway Mutant Endometrial Cancer

Phase 1 Not yet recruiting

Phase IB